Nicotine Addiction and Psychiatric Disorders

International Review of Neurobiology

Volumn 124, Issue , 2015, Pages 171-208

  Kutlu, Munir Gunes ^a   Parikh, Vinay ^a   Gould, Thomas J ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

ADHD; Anxiety disorders; Depression; Nicotine; Nicotinic receptors; PTSD

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; 4 CHLORO N (3 QUINUCLIDINYL)BENZAMIDE; BUNGAROTOXIN RECEPTOR; DONEPEZIL; ISPRONICLINE; MECAMYLAMINE; METABOTROPIC RECEPTOR 2; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3; NICOTINIC RECEPTOR ALPHA4BETA2; NICOTINIC RECEPTOR ALPHA5; NICOTINIC RECEPTOR ALPHA6; NICOTINIC RECEPTOR BETA4; UNCLASSIFIED DRUG; NICOTINE;

ANXIETY; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; CHOLINERGIC SYSTEM; CLINICAL FEATURE; COGNITION ASSESSMENT; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; EPIGENETICS; HUMAN; NEUROMODULATION; NONHUMAN; PATHOGENESIS; POPULATION DISTRIBUTION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REGULATORY MECHANISM; SMOKING CESSATION; SUSCEPTIBLE POPULATION; TOBACCO DEPENDENCE; UPREGULATION; COMPLICATION; MENTAL DISEASE; METABOLISM;

HUMANS; MENTAL DISORDERS; NICOTINE; RECEPTORS, NICOTINIC; TOBACCO USE DISORDER;

EID: 84941749622     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.irn.2015.08.004     Document Type: Chapter

References (232)

1. Alkondon M., Albuquerque E.X. The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Progress in Brain Research 2004, 145:109-120.
2. Allison C., Shoaib M. Nicotine improves performance in an attentional set shifting task in rats. Neuropharmacology 2013, 64:314-320.
3. American Psychiatric Association DSM 5 2013, American Psychological Association, Washington, DC.
4. Ameringer K.J., Leventhal A.M. Symptom dimensions of attention deficit hyperactivity disorder and nicotine withdrawal symptoms. Journal of Addictive Diseases 2012, 31(4):363-375.
5. André J.M., Gulick D., Portugal G.S., Gould T.J. Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice. Behavioural Brain Research 2008, 190(2):174-181.
6. Andreasen J.T., Henningsen K., Bate S., Christiansen S., Wiborg O. Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: Comparison with sertraline. Journal of Psychopharmacology 2011, 25(8):1134-1141.
7. Andreasen J.T., Nielsen E.Ø., Redrobe J.P. Chronic oral nicotine increases brain [3H] epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test. Psychopharmacology 2009, 205(3):517-528.
8. Andreasen J.T., Olsen G.M., Wiborg O., Redrobe J.P. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests. Journal of Psychopharmacology 2009, 23(7):797-804.
9. Andreasen J.T., Redrobe J.P. Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: Role of strain, test and sex. Behavioural Pharmacology 2009, 20(3):286-295.
10. Arnold H.M., Burk J.A., Hodgson E.M., Sarter M., Bruno J.P. Differential acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention. Neuroscience 2002, 114(2):451-460.
11. Ashare R.L., Falcone M., Lerman C. Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology 2014, 76:581-591.
12. Bailey C.D., De Biasi M., Fletcher P.J., Lambe E.K. The nicotinic acetylcholine receptor α5 subunit plays a key role in attention circuitry and accuracy. The Journal of Neuroscience 2010, 30(27):9241-9252.
13. Bailey C.D., Tian M.K., Kang L., O'Reilly R., Lambe E.K. Chrna5 genotype determines the long-lasting effects of developmental in vivo nicotine exposure on prefrontal attention circuitry. Neuropharmacology 2014, 77:145-155.
14. Barbaresi W.J., Katusic S.K., Colligan R.C., Pankratz V.S., Weaver A.L., Weber K.J., et al. How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minnesota. Archives of Pediatrics & Adolescent Medicine 2002, 156(3):217-224.
15. Barbaresi W., Katusic S., Colligan R., Weaver A., Pankratz V., Mrazek D., et al. How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: Results from a population-based study. Acta Paediatrica 2004, 93(s445):55-59.
16. Bari A., Dalley J.W., Robbins T.W. The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nature Protocols 2008, 3(5):759-767.
17. Beane M., Marrocco R.T. Norepinephrine and acetylcholine mediation of the components of reflexive attention: Implications for attention deficit disorders. Progress in Neurobiology 2004, 74(3):167-181.
18. Beckham J.C., Calhoun P.S., Dennis M.F., Wilson S.M., Dedert E.A. Predictors of lapse in first week of smoking abstinence in PTSD and non-PTSD smokers. Nicotine & Tobacco Research 2012, 15(6):1122-1129.
19. Beckham J.C., Feldman M.E., Vrana S.R., Mozley S.L., Erkanli A., Clancy C.P., et al. Immediate antecedents of cigarette smoking in smokers with and without posttraumatic stress disorder: A preliminary study. Experimental and Clinical Psychopharmacology 2005, 13(3):219.
20. Blechert J., Michael T., Vriends N., Margraf J., Wilhelm F.H. Fear conditioning in posttraumatic stress disorder: Evidence for delayed extinction of autonomic, experiential, and behavioural responses. Behaviour Research and Therapy 2007, 45(9):2019-2033.
21. Breslau N., Davis G.C., Schultz L.R. Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma. Archives of General Psychiatry 2003, 60(3):289-294.
22. Breslau N., Johnson E.O. Predicting smoking cessation and major depression in nicotine-dependent smokers. American Journal of Public Health 2000, 90(7):1122.
23. Breslau N., Kilbey M., Andreski P. Nicotine dependence, major depression, and anxiety in young adults. Archives of General Psychiatry 1991, 48(12):1069-1074.
24. Breslau N., Novak S.P., Kessler R.C. Psychiatric disorders and stages of smoking. Biological Psychiatry 2004, 55(1):69-76.
25. Brioni J.D., O'Neill A.B., Kim D.J., Buckley M.J., Decker M.W., Arneric S.P. Anxiolytic-like effects of the novel cholinergic channel activator ABT-418. Journal of Pharmacology and Experimental Therapeutics 1994, 271(1):353-361.
26. Briscione M.A., Jovanovic T., Norrholm S.D. Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors. Frontiers in Psychiatry 2014, 5:88.
27. Brook J.S., Schuster E., Zhang C. Cigarette smoking and depressive symptoms: A longitudinal study of adolescents and young adults. Psychological Reports 2004, 95(1):159-166.
28. Caldarone B.J., Harrist A., Cleary M.A., Beech R.D., King S.L., Picciotto M.R. High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation. Biological Psychiatry 2004, 56(9):657-664.
29. Carmody T.P. Affect regulation, nicotine addiction, and smoking cessation. Journal of Psychoactive Drugs 1992, 24(2):111-122.
30. Castellanos F.X., Margulies D.S., Kelly C., Uddin L.Q., Ghaffari M., Kirsch A., et al. Cingulate-precuneus interactions: A new locus of dysfunction in adult attention-deficit/hyperactivity disorder. Biological Psychiatry 2008, 63(3):332-337.
31. Centers for Disease Control Trends in current cigarette smoking among high school students and adults, United States, 1965-2007 2008.
32. Centers for Disease Control and Prevention (CDC) Tobacco use among middle and high school students-United States, 2000-2009. MMWR. Morbidity and Mortality Weekly Report 2010, 59(33):1063.
33. Choi W.S., Patten C.A., Gillin J.C., Kaplan R.M., Pierce J.P. Cigarette smoking predicts development of depressive symptoms among US adolescents. Annals of Behavioral Medicine 1997, 19(1):42-50.
34. Christianson J.P., Fernando A.B., Kazama A.M., Jovanovic T., Ostroff L.E., Sangha S. Inhibition of fear by learned safety signals: A mini-symposium review. The Journal of Neuroscience 2012, 32(41):14118-14124.
35. Clark R.E., Squire L.R. Classical conditioning and brain systems: The role of awareness. Science 1998, 280(5360):77-81.
36. Cohen B.N., Mackey E.D., Grady S.R., McKinney S., Patzlaff N.E., Wageman C.R., et al. Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior. Neuroscience 2012, 200:31-41.
37. Counotte D.S., Goriounova N.A., Li K.W., Loos M., Van Der Schors R.C., Schetters D., et al. Lasting synaptic changes underlie attention deficits caused by nicotine exposure during adolescence. Nature Neuroscience 2011, 14(4):417-419.
38. Covey L.S., Glassman A.H., Stetner F. Major depression following smoking cessation. The American Journal of Psychiatry 1997, 154(2):263.
39. Covey L.S., Glassman A.H., Stetner F. Cigarette smoking and major depression. Journal of Addictive Diseases 1998, 17(1):35-46.
40. Czermak C., Staley J.K., Kasserman S., Bois F., Young T., Henry S., et al. β2 Nicotinic acetylcholine receptor availability in post-traumatic stress disorder. The International Journal of Neuropsychopharmacology 2008, 11(03):419-424.
41. Dalack G.W., Glassman A.H., Rivelli S., Covey L., Stetner F. Mood, major depression, and fluoxetine response in cigarette smokers. American Journal of Psychiatry 1995, 152:398-403.
42. Dani J.A., Heinemann S. Molecular and cellular aspects of nicotine abuse. Neuron 1996, 16(5):905-908.
43. Davis M., Falls W.A., Gewirtz J. Neural systems involved in fear inhibition: Extinction and conditioned inhibition. Contemporary issues in modeling psychopathology 2000, 113-141. Kluwer Academic Publishers, Boston. M.S. Myslobodsky, I. Weiner (Eds.).
44. Davis J.A., Gould T.J. The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice. Psychopharmacology 2006, 184(3-4):345-352.
45. Davis J.A., Gould T.J. β2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice. Psychopharmacology 2007, 190(3):343-352.
46. Davis J.A., Gould T.J. Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits. European Neuropsychopharmacology 2009, 19(8):551-561.
47. Davis J.A., James J.R., Siegel S.J., Gould T.J. Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. The Journal of Neuroscience 2005, 25(38):8708-8713.
48. Davis J.A., Kenney J.W., Gould T.J. Hippocampal α4β2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. The Journal of Neuroscience 2007, 27(40):10870-10877.
49. Davis J.A., Porter J., Gould T.J. Nicotine enhances both foreground and background contextual fear conditioning. Neuroscience Letters 2006, 394(3):202-205.
50. Decker M.W., Brioni J.D., Bannon A.W., Arneric S.P. Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for CNS therapeutics. Life Sciences 1995, 56(8):545-570.
51. Decker M.W., Brioni J.D., Sullivan J.P., Buckley M.J., Radek R.J., Raszkiewicz J.L., et al. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization. Journal of Pharmacology and Experimental Therapeutics 1994, 270(1):319-328.
52. Dedert E.A., Calhoun P.S., Harper L.A., Dutton C.E., McClernon F.J., Beckham J.C. Smoking withdrawal in smokers with and without posttraumatic stress disorder. Nicotine & Tobacco Research 2011, 14(3):372-376.
53. Dovis S., Van der Oord S., Huizenga H.M., Wiers R.W., Prins P.J. Prevalence and diagnostic validity of motivational impairments and deficits in visuospatial short-term memory and working memory in ADHD subtypes. European Child & Adolescent psychiatry 2014, 24(5):575-590.
54. Elias G.A., Gulick D., Wilkinson D.S., Gould T.J. Nicotine and extinction of fear conditioning. Neuroscience 2010, 165(4):1063-1073.
55. English B.A., Hahn M.K., Gizer I.R., Mazei-Robison M., Steele A., Kurnik D.M., et al. Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. Journal of Neurodevelopmental Disorders 2009, 1(4):252-263.
56. Ericson M., Olausson P., Engel J.A., Söderpalm B. Nicotine induces disinhibitory behavior in the rat after subchronic peripheral nicotinic acetylcholine receptor blockade. European Journal of Pharmacology 2000, 397(1):103-111.
57. Feldner M.T., Babson K.A., Zvolensky M.J. Smoking, traumatic event exposure, and post-traumatic stress: A critical review of the empirical literature. Clinical Psychology Review 2007, 27(1):14-45.
58. Fergusson D.M., Goodwin R.D., Horwood L.J. Major depression and cigarette smoking: Results of a 21-year longitudinal study. Psychological Medicine 2003, 33(08):1357-1367.
59. File S.E., Kenny P.J., Ouagazzal A.M. Bimodal modulation by nicotine of anxiety in the social interaction test: Role of the dorsal hippocampus. Behavioral Neuroscience 1998, 112(6):1423.
60. Fu S.S., McFall M., Saxon A.J., Beckham J.C., Carmody T.P., Baker D.G., et al. Post-traumatic stress disorder and smoking: A systematic review. Nicotine & Tobacco Research 2007, 9(11):1071-1084.
61. Fuemmeler B.F., Kollins S.H., McClernon F.J. Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood. Journal of Pediatric Psychology 2007, 32(10):1203-1213.
62. Gangitano D., Salas R., Teng Y., Perez E., De Biasi M. Progesterone modulation of α5 nAChR subunits influences anxiety-related behavior during estrus cycle. Genes, Brain and Behavior 2009, 8(4):398-406.
63. Gatto G.J., Bohme G.A., Caldwell W.S., Letchworth S.R., Traina V.M., Obinu M.C., et al. TC-1734: An orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects. CNS Drug Reviews 2004, 10(2):147-166.
64. Gehricke J.G., Loughlin S.E., Whalen C.K., Potkin S.G., Fallon J.H., Jamner L.D., et al. Smoking to self-medicate attentional and emotional dysfunctions. Nicotine & Tobacco Research 2007, 9(Suppl. 4):S523-S536.
65. Glassman A.H., Covey L.S., Stetner F., Rivelli S. Smoking cessation and the course of major depression: A follow-up study. The Lancet 2001, 357(9272):1929-1932.
66. Glassman A.H., Helzer J.E., Covey L.S., Cottler L.B., Stetner F., Tipp J.E., et al. Smoking, smoking cessation, and major depression. JAMA 1990, 264(12):1546-1549.
67. Glassman A.H., Stetner F., Walsh T., Raizman P.S., Fleiss J.L., Cooper T.B., et al. Heavy smokers, smoking cessation, and clonidine. Journal of the American Medical Association 1988, 259:2863-2866.
68. Goodman E., Capitman J. Depressive symptoms and cigarette smoking among teens. Pediatrics 2000, 106(4):748-755.
69. Goodwin R.D., Lewinsohn P.M., Seeley J.R. Cigarette smoking and panic attacks among young adults in the community: The role of parental smoking and anxiety disorders. Biological Psychiatry 2005, 58(9):686-693.
70. Gotti C., Clementi F., Fornari A., Gaimarri A., Guiducci S., Manfredi I., et al. Structural and functional diversity of native brain neuronal nicotinic receptors. Biochemical Pharmacology 2009, 78:703-711.
71. Gould T.J. Nicotine produces a within-subject enhancement of contextual fear conditioning in C57BL/6 mice independent of sex. Integrative Physiological & Behavioral Science 2003, 38(2):124-132.
72. Gould T.J., Feiro O., Moore D. Nicotine enhances trace cued fear conditioning but not delay cued fear conditioning in C57BL/6 mice. Behavioural Brain Research 2004, 155(1):167-173.
73. Gould T.J., Higgins J. Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training. Neurobiology of Learning and Memory 2003, 80(2):147-157.
74. Gould T.J., Leach P.T. Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning. Neurobiology of Learning and Memory 2014, 107:108-132.
75. Gould T.J., Portugal G.S., Andre J.M., Tadman M.P., Marks M.J., Kenney J.W., et al. The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation. Neuropharmacology 2012, 62:2118-2125.
76. Gould T.J., Wehner J.M. Nicotine enhancement of contextual fear conditioning. Behavioural Brain Research 1999, 102(1):31-39.
77. Gould T.J., Wilkinson D.S., Yildirim E., Blendy J.A., Adoff M.D. Dissociation of tolerance and nicotine withdrawal-associated deficits in contextual fear. Brain Research 2014, 1559:1-10.
78. Grant B.F., Hasin D.S., Chou S.P., Stinson F.S., Dawson D.A. Nicotine dependence and psychiatric disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry 2004, 61(11):1107-1115.
79. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry 2004, 61(8):807-816.
80. Greenberg J.B., Ameringer K.J., Trujillo M.A., Sun P., Sussman S., Brightman M., et al. Associations between posttraumatic stress disorder symptom clusters and cigarette smoking. Psychology of Addictive Behaviors 2012, 26(1):89.
81. Greenberg P.E., Sisitsky T., Kessler R.C., Finkelstein S.N., Berndt E.R., Davidson J.R., et al. The economic burden of anxiety disorders in the 1990s. The Journal of Clinical Psychiatry 1999, 60(7):427-435.
82. Grottick A.J., Higgins G.A. Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behavioural Brain Research 2000, 117(1):197-208.
83. Hahn B., Shoaib M., Stolerman I. Nicotine-induced enhancement of attention in the five-choice serial reaction time task: The influence of task demands. Psychopharmacology 2002, 162(2):129-137.
84. Hahn B., Stolerman I.P. Nicotine-induced attentional enhancement in rats: Effects of chronic exposure to nicotine. Neuropsychopharmacology 2002, 27(5):712-722.
85. Hall S.M., Muñoz R.F., Reus V.I., Sees K.L. Nicotine, negative affect, and depression. Journal of Consulting and Clinical Psychology 1993, 61(5):761.
86. Hammerness P., Joshi G., Doyle R., Georgiopoulos A., Geller D., Spencer T., et al. Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate. The Journal of Pediatrics 2013, 162(1):22-27.
87. Hampson M., Driesen N.R., Skudlarski P., Gore J.C., Constable R.T. Brain connectivity related to working memory performance. The Journal of Neuroscience 2006, 26(51):13338-13343.
88. Hapke U., Schumann A., Rumpf H.J., John U., Konerding U., Meyer C. Association of smoking and nicotine dependence with trauma and posttraumatic stress disorder in a general population sample. The Journal of Nervous and Mental Disease 2005, 193(12):843-846.
89. Hogg R.C., Raggenbass M., Bertrand D. Nicotinic acetylcholine receptors: from structure to brain function. Reviews of Physiology, Biochemistry and Pharmacology 2003, 147:1-46.
90. Howe W.M., Berry A.S., Francois J., Gilmour G., Carp J.M., Tricklebank M., et al. Prefrontal cholinergic mechanisms instigating shifts from monitoring of cues to cues-guided performance: Converging electrochemical and fMRI evidence from rats and humans. The Journal of Neuroscience 2013, 33(20):8742-8752.
91. Howe W.M., Ji J., Parikh V., Williams S., Mocaër E., Trocmé-Thibierge C., et al. Enhancement of attentional performance by selective stimulation of α4β2* nAChRs: Underlying cholinergic mechanisms. Neuropsychopharmacology 2010, 35(6):1391-1401.
92. Hoyle E., Genn R.F., Fernandes C., Stolerman I.P. Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacology 2006, 189(2):211-223.
93. Hughes J.R., Keenan R.M., Yellin A. Effect of tobacco withdrawal on sustained attention. Addictive Behaviors 1989, 14(5):577-580.
94. Indredavik M.S., Brubakk A.M., Romundstad P., Vik T. Prenatal smoking exposure and psychiatric symptoms in adolescence. Acta Paediatrica 2007, 96(3):377-382.
95. Irvine E.E., Cheeta S., File S.E. Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behavioural Pharmacology 1999, 10(6-7):691-697.
96. Irvine E.E., Cheeta S., File S.E. Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal. Pharmacology Biochemistry and Behavior 2001, 68(2):319-325.
97. Ischaki E., Gratziou C. Smoking and depression: Is smoking cessation effective?. Therapeutic Advances in Respiratory Disease 2009, 3(1):31-38.
98. Jacobsen L.K., Krystal J.H., Mencl W.E., Westerveld M., Frost S.J., Pugh K.R. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biological Psychiatry 2005, 57(1):56-66.
99. John U., Meyer C., Rumpf H.J., Hapke U. Smoking, nicotine dependence and psychiatric comorbidity-A population-based study including smoking cessation after three years. Drug and Alcohol Dependence 2004, 76(3):287-295.
100. Jones S., Sudweeks S., Yakel J.L. Nicotinic receptors in the brain: Correlating physiology with function. Trends in Neurosciences 1999, 22(12):555-561.
101. Jovanovic T., Kazama A., Bachevalier J., Davis M. Impaired safety signal learning may be a biomarker of PTSD. Neuropharmacology 2012, 62(2):695-704.
102. Jovanovic T., Norrholm S.D., Blanding N.Q., Davis M., Duncan E., Bradley B., et al. Impaired fear inhibition is a biomarker of PTSD but not depression. Depression and Anxiety 2010, 27(3):244-251.
103. Jovanovic T., Norrholm S.D., Fennell J.E., Keyes M., Fiallos A.M., Myers K.M., et al. Posttraumatic stress disorder may be associated with impaired fear inhibition: Relation to symptom severity. Psychiatry Research 2009, 167(1):151-160.
104. Kenney J.W., Raybuck J.D., Gould T.J. Nicotinic receptors in the dorsal and ventral hippocampus differentially modulate contextual fear conditioning. Hippocampus 2012, 22(8):1681-1690.
105. Kessler R.C. The prevalence of psychiatric comorbidity. Treatment strategies for patients with psychiatric comorbidity 1997, John Wiley & Sons, New York. S. Wetzler, W.C. Sanderson (Eds.).
106. Kessler R.C., Adler L., Barkley R., Biederman J., Conners C.K., Demler O., et al. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. The American Journal of Psychiatry 2006, 163(4):716-723.
107. Kessler R.C., Chiu W.T., Demler O., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62(6):617-627.
108. Killen J.D., Robinson T.N., Ammerman S., Hayward C., Rogers J., Samuels D., et al. Major depression among adolescent smokers undergoing treatment for nicotine dependence. Addictive Behaviors 2004, 29(8):1517-1526.
109. Klungsøyr O., Nygård J.F., Sørensen T., Sandanger I. Cigarette smoking and incidence of first depressive episode: An 11-year, population-based follow-up study. American Journal of Epidemiology 2006, 163(5):421-432.
110. Koenen K.C., Hitsman B., Lyons M.J., Niaura R., McCaffery J., Goldberg J., et al. A twin registry study of the relationship between posttraumatic stress disorder and nicotine dependence in men. Archives of General Psychiatry 2005, 62(11):1258-1265.
111. Kollins S.H., English J.S., Roley M.E., O'Brien B., Blair J., Lane S.D., et al. Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder. Psychopharmacology 2013, 227(1):19-30.
112. Kuryatov A., Luo J., Cooper J., Lindstrom J. Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. Molecular Pharmacology 2005, 68:1839-1851.
113. Kutlu M.G., Gould T.J. Acute nicotine delays extinction of contextual fear in mice. Behavioural Brain Research 2014, 263:133-137.
114. Kutlu M.G., Oliver C., Gould T.J. The effects of acute nicotine on contextual safety discrimination. Journal of Psychopharmacology 2014, 28(11):1064-1070. 10.1177/0269881114552743.
115. Labarca C., Schwarz J., Deshpande P., Schwarz S., Nowak M.W., Fonck C., et al. Point mutant mice with hypersensitive α4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(5):2786-2791.
116. Lambert N.M., Hartsough C.S. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. Journal of Learning Disabilities 1998, 31(6):533-544.
117. Lanius R.A., Williamson P.C., Densmore M., Boksman K., Gupta M.A., Neufeld R.W., et al. Neural correlates of traumatic memories in posttraumatic stress disorder: A functional MRI investigation. American Journal of Psychiatry 2001, 158(11):1920-1922.
118. Lasser K., Boyd J.W., Woolhandler S., Himmelstein D.U., McCormick D., Bor D.H. Smoking and mental illness: A population-based prevalence study. JAMA 2000, 284(20):2606-2610.
119. Leach P.T., Cordero K.A., Gould T.J. The effects of acute nicotine, chronic nicotine, and withdrawal from chronic nicotine on performance of a cued appetitive response. Behavioral Neuroscience 2013, 127(2):303.
120. Lee C.T., Fuemmeler B.F., McClernon F.J., Ashley-Koch A., Kollins S.H. Nicotinic receptor gene variants interact with attention deficient hyperactive disorder symptoms to predict smoking trajectories from early adolescence to adulthood. Addictive Behaviors 2013, 38(11):2683-2689.
121. Lerman C., Audrain J., Orleans C.T., Boyd R., Gold K., Main D., et al. Investigation of mechanisms linking depressed mood to nicotine dependence. Addictive Behaviors 1996, 21:9-19.
122. Levin E.D., Conners C.K., Sparrow E., Hinton S.C., Erhardt D., Meck W.H., et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 1996, 123(1):55-63.
123. Lissek S., Powers A.S., McClure E.B., Phelps E.A., Woldehawariat G., Grillon C., et al. Classical fear conditioning in the anxiety disorders: A meta-analysis. Behaviour Research and Therapy 2005, 43(11):1391-1424.
124. Lister R.G. Ethologically-based animal models of anxiety disorders. Pharmacology & Therapeutics 1990, 46(3):321-340.
125. Logue S.F., Paylor R., Wehner J.M. Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task. Behavioral Neuroscience 1997, 111(1):104.
126. Lotfipour S., Byun J.S., Leach P., Fowler C.D., Murphy N.P., Kenny P.J., et al. Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors. The Journal of Neuroscience 2013, 33(18):7728-7741.
127. Markou A., Kosten T.R., Koob G.F. Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology 1998, 18(3):135-174.
128. Marks M.J., Burch J.B., Collins A.C. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. Journal of Pharmacology and Experimental Therapeutics 1983, 226:817-825.
129. Marks M.J., Collins A.C. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Molecular Pharmacology 1982, 22(3):554-564.
130. Marks M.J., Grady S.R., Collins A.C. Downregulation of nicotinic receptor function after chronic nicotine infusion. Journal of Pharmacology and Experimental Therapeutics 1993, 266(3):1268-1276.
131. Matta S.G., Balfour D.J., Benowitz N.L., Boyd R.T., Buccafusco J.J., Caggiula A.R., et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 2007, 190(3):269-319.
132. Matthews K., Christmas D., Swan J., Sorrell E. Animal models of depression: Navigating through the clinical fog. Neuroscience & Biobehavioral Reviews 2005, 29(4):503-513.
133. McClernon F.J., Van Voorhees E.E., English J., Hallyburton M., Holdaway A., Kollins S.H. Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: Results from a 12-day contingency-managed abstinence trial. Nicotine & Tobacco Research 2011, 13(9):784-792.
134. McEchron M.D., Bouwmeester H., Tseng W., Weiss C., Disterhoft J.F. Hippocampectomy disrupts auditory trace fear conditioning and contextual fear conditioning in the rat. Hippocampus 1998, 8(6):638-646.
135. McGaughy J., Kaiser T., Sarter M. Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: Selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behavioral Neuroscience 1996, 110(2):247-265.
136. McGehee D.S. Molecular diversity of neuronal nicotinic acetylcholine receptors. Annals of the New York Academy of Sciences 1999, 868(1):565-577.
137. McGranahan T.M., Patzlaff N.E., Grady S.R., Heinemann S.F., Booker T.K. α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. The Journal of Neuroscience 2011, 31(30):10891-10902.
138. Mendrek A., Monterosso J., Simon S.L., Jarvik M., Brody A., Olmstead R., et al. Working memory in cigarette smokers: Comparison to non-smokers and effects of abstinence. Addictive Behaviors 2006, 31(5):833-844.
139. Michael T., Blechert J., Vriends N., Margraf J., Wilhelm F.H. Fear conditioning in panic disorder: Enhanced resistance to extinction. Journal of Abnormal Psychology 2007, 116(3):612.
140. Mihailescu S., Drucker-Colin R. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Archives of Medical Research 2000, 31:131-144.
141. Mihalak K.B., Carroll F.I., Luetje C.W. Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors. Molecular Pharmacology 2006, 70(3):801-805.
142. Milad M.R., Pitman R.K., Ellis C.B., Gold A.L., Shin L.M., Lasko N.B., et al. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biological Psychiatry 2009, 66(12):1075-1082.
143. Milberger S., Biederman J., Faraone S.V., Chen L., Jones J. Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children?. The American Journal of Psychiatry 1996, 153(9):1138-1142.
144. Milberger S., Biederman J., Faraone S.V., Jones J. Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: Findings from a high-risk sample of siblings. Journal of Clinical Child Psychology 1998, 27(3):352-358.
145. Mineka S., Zinbarg R. A contemporary learning theory perspective on the etiology of anxiety disorders: It's not what you thought it was. American Psychologist 2006, 61(1):10.
146. Mineur Y.S., Picciotto M.R. Nicotine receptors and depression: Revisiting and revising the cholinergic hypothesis. Trends in Pharmacological Sciences 2010, 31(12):580-586.
147. Mirza N.R., Bright J.L. Nicotine-induced enhancements in the five-choice serial reaction time task in rats are strain-dependent. Psychopharmacology 2001, 154(1):8-12.
148. Moore J.D., Bona J.R. Advances in the pathophysiology and treatment of psychiatric disorders for internal medicine: Depression and dysthymia. Medical Clinics of North America 2001, 85:631-644.
149. Morrell H.E., Cohen L.M. Cigarette smoking, anxiety, and depression. Journal of Psychopathology and Behavioral Assessment 2006, 28(4):281-295.
150. Myers K.M., Davis M. Mechanisms of fear extinction. Molecular Psychiatry 2006, 12(2):120-150.
151. Nelson M.E., Kuryatov A., Choi C.H., Zhou Y., Lindstrom J. Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. Molecular Pharmacology 2003, 63:332-341.
152. Nunes E.V., Covey L.S., Brigham G., Hu M.C., Levin F.R., Somoza E., et al. Treating nicotine dependence by targeting attention deficit hyperactivity disorder (ADHD): The role of ADHD severity and treatment response in a randomized controlled trial. The Journal of Clinical Psychiatry 2013, 74(10):983.
153. Olale F., Gerzanich V., Kuryatov A., Wang F., Lindstrom J. Chronic nicotine exposure differentially affects the function of human alpha3, alpha4, and alpha7 neuronal nicotinic receptor subtypes. Journal of Pharmacology and Experimental Therapeutics 1997, 283:675-683.
154. O'Neill A.B., Brioni J.D. Benzodiazepine receptor mediation of the anxiolytic-like effect of (-)-nicotine in mice. Pharmacology Biochemistry and Behavior 1994, 49(3):755-757.
155. Ortega L.A., Tracy B.A., Gould T.J., Parikh V. Effects of chronic low-and high-dose nicotine on cognitive flexibility in C57BL/6J mice. Behavioural Brain Research 2013, 238:134-145.
156. Ouagazzal A.M., Kenny P.J., File S.E. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine. Psychopharmacology 1999, 144(1):54-60.
157. 1a receptor antagonist. Neuropharmacology 2013, 70:35-42.
158. Paperwalla K.N., Levin T.T., Weiner J., Saravay S.M. Smoking and depression. Medical Clinics of North America 2004, 88(6):1483-1494.
159. Papke R.L., Heinemann S.F. Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit. Molecular Pharmacology 1994, 45(1):142-149.
160. Parikh V., Kozak R., Martinez V., Sarter M. Prefrontal acetylcholine release cue detection on multiple time scales. Neuron 2007, 56(1):141-154.
161. Parikh V., Peters M.S., Blakely R.D., Sarter M. The presynaptic choline transporter imposes limits on sustained cortical acetylcholine release and attention. The Journal of Neuroscience 2013, 33(6):2326-2337.
162. Paylor R., Nguyen M., Crawley J.N., Patrick J., Beaudet A., Orr-Urtreger A. α7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: A behavioral characterization of Acra7-deficient mice. Learning & Memory 1998, 5(4):302-316.
163. Phillips R.G., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behavioral Neuroscience 1992, 106(2):274.
164. Picciotto M.R., Zoli M., Rimondini R., Léna C., Marubio L.M., Pich E.M., et al. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 1998, 391(6663):173-177.
165. Picciotto M.R., Caldarone B.J., King S.L., Zachariou V. Nicotinic receptors in the brain: links between molecular biology and behavior. Neuropsychopharmacology 2000, 22(5):451-465.
166. Polina E.R., Rovaris D.L., de Azeredo L.A., Mota N.R., Vitola E.S., Silva K.L., et al. ADHD diagnosis may influence the association between polymorphisms in nicotinic acetylcholine receptor genes and tobacco smoking. Neuromolecular Medicine 2014, 16(2):389-397.
167. Pomerleau O.F., Downey K.K., Stelson F.W., Pomerleau C.S. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. Journal of Substance Abuse 1995, 7(3):373-378.
168. Pomerleau O.F., Pomerleau C.S. Neuroregulators and the reinforcement of smoking: Towards a biobehavioral explanation. Neuroscience & Biobehavioral Reviews 1985, 8(4):503-513.
169. Pomerleau O.F., Pomerleau C.S., Marks J.L., Snedecor S.M., Mehringer A.M., Brouwer R.J.N., et al. Prolonged nicotine patch use in quitters with past abstinence-induced depressed mood. Journal of Substance Abuse Treatment 2003, 24(1):13-18.
170. Portugal G.S., Gould T.J. Nicotine withdrawal disrupts new contextual learning. Pharmacology Biochemistry and Behavior 2009, 92(1):117-123.
171. Portugal G.S., Kenney J.W., Gould T.J. β2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning. Neurobiology of Learning and Memory 2008, 89(2):106-113.
172. Portugal G.S., Wilkinson D.S., Kenney J.W., Sullivan C., Gould T.J. Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Behavior Genetics 2012, 42(1):133-150.
173. Potter A.S., Bucci D.J., Newhouse P.A. Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity. Psychopharmacology 2012, 220(2):331-340.
174. Potter A.S., Newhouse P.A. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder. Pharmacology Biochemistry and Behavior 2008, 88(4):407-417.
175. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2007, 33(1):56-72.
176. Rabenstein R.L., Caldarone B.J., Picciotto M.R. The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2-or α7-nicotinic acetylcholine receptor subunit knockout mice. Psychopharmacology 2006, 189(3):395-401.
177. Raybuck J.D., Gould T.J. Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice-A role for high-affinity β2 subunit-containing nicotinic acetylcholine receptors. European Journal of Neuroscience 2009, 29(2):377-387.
178. Rezvani A.H., Cauley M.C., Johnson E.C., Gatto G.J., Levin E.D. Effects of AZD3480, a neuronal nicotinic acetylcholine receptor agonist, and donepezil on dizocilpine-induced attentional impairment in rats. Psychopharmacology 2012, 223(3):251-258.
179. Rezvani A.H., Cauley M., Sexton H., Xiao Y., Brown M.L., Paige M.A., et al. Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: Effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats. Psychopharmacology 2011, 215(4):621-630.
180. Rezvani A.H., Cauley M., Xiao Y., Kellar K.J., Levin E.D. Effects of chronic sazetidine-A, a selective α4β2 neuronal nicotinic acetylcholine receptors desensitizing agent on pharmacologically-induced impaired attention in rats. Psychopharmacology 2013, 226(1):35-43.
181. Rodgers R.J. Animal models of 'anxiety': Where next?. Behavioural Pharmacology 1997, 8(6-7):477-496.
182. Rollema H., Guanowsky V., Mineur Y.S., Shrikhande A., Coe J.W., Seymour P.A., et al. Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect. European Journal of Pharmacology 2009, 605(1):114-116.
183. Ross S.A., Wong J.Y., Clifford J.J., Kinsella A., Massalas J.S., Horne M.K., et al. Phenotypic characterization of an α4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. The Journal of Neuroscience 2000, 20(17):6431-6441.
184. Rukstalis M., Jepson C., Patterson F., Lerman C. Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. Journal of Substance Abuse Treatment 2005, 28(4):297-304.
185. Salas R., Pieri F., Fung B., Dani J.A., De Biasi M. Altered anxiety-related responses in mutant mice lacking the β4 subunit of the nicotinic receptor. The Journal of Neuroscience 2003, 23(15):6255-6263.
186. Salminen O., Drapeau J.A., McIntosh J.M., Collins A.C., Marks M.J., Grady S.R. Pharmacology of α-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. Molecular Pharmacology 2007, 71(6):1563-1571.
187. Salminen O., Murphy K.L., McIntosh J.M., Drago J., Marks M.J., Collins A.C., et al. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Molecular Pharmacology 2004, 65(6):1526-1535.
188. Schleicher H.E., Harris K.J., Catley D., Nazir N. The role of depression and negative affect regulation expectancies in tobacco smoking among college students. Journal of American College Health 2009, 57(5):507-512.
189. Schneider T., Ilott N., Brolese G., Bizarro L., Asherson P.J., Stolerman I.P. Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats. Neuropsychopharmacology 2011, 36(5):1114-1125.
190. Schoenfelder E.N., Faraone S.V., Kollins S.H. Stimulant treatment of ADHD and cigarette smoking: A meta-analysis. Pediatrics 2014, 133(6):1070-1080.
191. Schwartz R.D., Kellar K.J. Nicotinic cholinergic receptor binding sites in the brain: Regulation in vivo. Science 1983, 220:214-216.
192. Semba J.I., Mataki C., Yamada S., Nankai M., Toru M. Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats. Biological Psychiatry 1998, 43(5):389-391.
193. Semenova S., Stolerman I.P., Markou A. Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats. Pharmacology Biochemistry and Behavior 2007, 87(3):360-368.
194. Shin L.M., Rauch S.L., Pitman R.K. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Annals of the New York Academy of Sciences 2006, 1071(1):67-79.
195. Shoaib M., Bizarro L. Deficits in a sustained attention task following nicotine withdrawal in rats. Psychopharmacology 2005, 178(2-3):211-222.
196. Slotkin T.A., Seidler F.J., Qiao D., Aldridge J.E., Tate C.A., Cousins M.M., et al. Effects of prenatal nicotine exposure on primate brain development and attempted amelioration with supplemental choline or vitamin C: Neurotransmitter receptors, cell signaling and cell development biomarkers in fetal brain regions of rhesus monkeys. Neuropsychopharmacology 2005, 30(1):129-144.
197. Solomon P.R., Vander Schaaf E.R., Thompson R.F., Weisz D.J. Hippocampus response. Behavioral Neuroscience 1986, 100(5):729.
198. Sonntag H., Wittchen H.U., Höfler M., Kessler R.C., Stein M.B. Are social fears and DSM-IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults?. European Psychiatry 2000, 15(1):67-74.
199. Stone E.A., Lin Y. Open-space forced swim model of depression for mice. Current Protocols in Neuroscience 2011, 54:9.36.1-9.36.8.
200. Strine T., Mokdad A., Balluz L., Gonzalez O., Crider R., Berry J., et al. Depression and anxiety in the United States: Findings from the 2006 behavioral risk factor surveillance system. Psychiatric Services 2008, 59(12):1383-1390.
201. Suemaru K., Yasuda K., Cui R., Li B., Umeda K., Amano M., et al. Antidepressant-like action of nicotine in forced swimming test and brain serotonin in mice. Physiology & Behavior 2006, 88(4):545-549.
202. Swan G.E., Ward M.M., Jack L.M. Abstinence effects as predictors of 28-day relapse in smokers. Addictive Behaviors 1996, 21:481-490.
203. Tarantino L.M., Gould T.J., Druhan J.P., Bucan M. Behavior and mutagenesis screens: The importance of baseline analysis of inbred strains. Mammalian Genome 2000, 11(7):555-564.
204. Tercyak K.P., Lerman C., Audrain J. Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. Journal of the American Academy of Child & Adolescent Psychiatry 2002, 41(7):799-805.
205. Thakur G.A., Sengupta S.M., Grizenko N., Schmitz N., Pagé V., Joober R. Maternal smoking during pregnancy and ADHD: A comprehensive clinical and neurocognitive characterization. Nicotine & Tobacco Research 2013, 15(1):149-157.
206. Thorndike F.P., Wernicke R., Pearlman M.Y., Haaga D.A. Nicotine dependence, PTSD symptoms, and depression proneness among male and female smokers. Addictive Behaviors 2006, 31(2):223-231.
207. Tian S., Gao J., Han L., Fu J., Li C., Li Z. Prior chronic nicotine impairs cued fear extinction but enhances contextual fear conditioning in rats. Neuroscience 2008, 153(4):935-943.
208. Tizabi Y., Getachew B., Rezvani A.H., Hauser S.R., Overstreet D.H. Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33(3):398-402.
209. Tizabi Y., Overstreet D.H., Rezvani A.H., Louis V.A., Clark E., Janowsky D.S., et al. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology 1999, 142(2):193-199.
210. Treur, J. L., Willemsen, G., Bartels, M., Geels, L. M., van Beek, J. H., Huppertz, C., et al. (in press). Smoking during adolescence as a risk factor for attention problems. Biological Psychiatry.
211. Tronson N.C., Schrick C., Guzman Y.F., Huh K.H., Srivastava D.P., Penzes P., et al. Segregated populations of hippocampal principal CA1 neurons mediating conditioning and extinction of contextual fear. The Journal of Neuroscience 2009, 29(11):3387-3394.
212. Turner J.R., Castellano L.M., Blendy J.A. Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior. Journal of Pharmacology and Experimental Therapeutics 2010, 334(2):665-672.
213. Vansickel A.R., Stoops W.W., Glaser P.E., Poole M.M., Rush C.R. Methylphenidate increases cigarette smoking in participants with ADHD. Psychopharmacology 2011, 218(2):381-390.
214. Vázquez-Palacios G., Bonilla-Jaime H., Velázquez-Moctezuma J. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2005, 29(1):39-46.
215. Viñals X., Molas S., Gallego X., Fernández-Montes R.D., Robledo P., Dierssen M., et al. Overexpression of α3/α5/β4 nicotinic receptor subunits modifies impulsive-like behavior. Drug and Alcohol Dependence 2012, 122(3):247-252.
216. Wehner J.M., Keller J.J., Keller A.B., Picciotto M.R., Paylor R., Booker T.K., et al. Role of neuronal nicotinic receptors in the effects of nicotine and ethanol on contextual fear conditioning. Neuroscience 2004, 129(1):11-24.
217. Weiss M., Murray C. ADHD and driving safety. Canadian Medical Association Journal 2003, 169(1):16-17.
218. West R.J., Hajek P., Belcher M. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychological Medicine 1989, 19:981-985.
219. Whiteaker P., Davies A.R., Marks M.J., Blagbrough I.S., Potter B.V., Wolstenholme A.J., et al. An autoradiographic study of the distribution of binding sites for the novel α7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. European Journal of Neuroscience 1999, 11(8):2689-2696.
220. Wigestrand M.B., Mineur Y.S., Heath C.J., Fonnum F., Picciotto M.R., Walaas S.I. Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD. Journal of Neurochemistry 2011, 119(1):240-250.
221. Wilens T.E., Vitulano M., Upadhyaya H., Adamson J., Sawtelle R., Utzinger L., et al. Cigarette smoking associated with attention deficit hyperactivity disorder. The Journal of Pediatrics 2008, 153(3):414-419.
222. Wilkinson D.S., Gould T.J. Withdrawal from chronic nicotine and subsequent sensitivity to nicotine challenge on contextual learning. Behavioural Brain Research 2013, 250:58-61.
223. Wu L.T., Anthony J.C. Tobacco smoking and depressed mood in late childhood and early adolescence. American Journal of Public Health 1999, 89(12):1837-1840.
224. Xiao Y., Fan H., Musachio J.L., Wei Z.L., Chellappan S.K., Kozikowski A.P., et al. Sazetidine-A, a novel ligand that desensitizes α4β2 nicotinic acetylcholine receptors without activating them. Molecular Pharmacology 2006, 70(4):1454-1460.
225. Yochum C., Doherty-Lyon S., Hoffman C., Hossain M.M., Zelikoff J.T., Richardson J.R. Prenatal cigarette smoke exposure causes hyperactivity and aggressive behavior: Role of altered catecholamines and BDNF. Experimental Neurology 2014, 254:145-152.
226. Yohn N.L., Turner J.R., Blendy J.A. Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors. Journal of Pharmacology and Experimental Therapeutics 2014, 349(2):348-354.
227. Young J.W., Finlayson K., Spratt C., Marston H.M., Crawford N., Kelly J.S., et al. Nicotine improves sustained attention in mice: Evidence for involvement of the α7 nicotinic acetylcholine receptor. Neuropsychopharmacology 2004, 29(5):891-900.
228. Young J.W., Meves J.M., Geyer M.A. Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test. Behavioural Brain Research 2013, 240:119-133.
229. Zhu J., Lee K.P., Spencer T.J., Biederman J., Bhide P.G. Transgenerational transmission of hyperactivity in a mouse model of ADHD. The Journal of Neuroscience 2014, 34(8):2768-2773.
230. Zhu J., Zhang X., Xu Y., Spencer T.J., Biederman J., Bhide P.G. Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover, and responsiveness to oral methylphenidate treatment. The Journal of Neuroscience 2012, 32(27):9410-9418.
231. Ziedonis D., Hitsman B., Beckham J.C., Zvolensky M., Adler L.E., Audrain-McGovern J., et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research 2008, 10(12):1691-1715.
232. Zwart R., Vijverberg H.P. Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Molecular Pharmacology 1998, 54:1124-1131.